Effects of Expiratory Muscle Strength Training in Adolescent Idiopathic Scoliosis
Launched by GAZI UNIVERSITY · Dec 20, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special type of exercise called expiratory muscle strength training on adolescents with a condition known as adolescent idiopathic scoliosis (AIS). AIS is a curvature of the spine that often develops during growth and can weaken core muscles and affect breathing. The researchers want to find out if this training can improve not only the strength of muscles used for breathing but also help stabilize the trunk, improve physical abilities, and enhance overall quality of life for these young individuals.
To participate in the trial, eligible candidates must be between 10 and 19 years old and diagnosed with idiopathic scoliosis, with a specific curve measurement (Cobb angle) between 10 and 45 degrees. However, those who have had spinal surgery, received treatment for scoliosis, or have certain other health conditions may not qualify. Participants can expect to engage in a training program designed to strengthen their respiratory muscles and core stability, with the goal of improving their physical function and well-being. This trial is important because it explores a new approach to managing scoliosis that hasn't been thoroughly researched before.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Individuals diagnosed with idiopathic scoliosis,
- • aged between 10 and 19 years,
- • with a Cobb angle ranging from 10 to 45 degrees.
- Exclusion Criteria:
- • Individuals who have undergone spinal surgery,
- • who have received conservative or surgical treatment for scoliosis,
- • individuals with neurological, neuromuscular, systemic, rheumatological, or musculoskeletal disorders, or conditions affecting balance and walking,
- • individuals with a history of cardiac or pulmonary diseases that could affect respiratory function and exercise capacity.
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, Yenimahalle, Turkey
Patients applied
Trial Officials
Muserrefe Nur Keles, PhD
Study Chair
Gazi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported